학술논문
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
Document Type
Article
Author
Aboagye, J; Ambihapathy, W; Baker, JF; Beales, ER; Boon, A; Brampton, R; Branch, NM; Cooper, R; Cornish, EL; Cuevas-Asturias, S; Danos, Z; Davies, S; de Luna George, L; Drury, R; Flaxman, A; Fowler, J; Galiza, E; Godfrey, L; Haskell, L; Hillson, K; Hultin, CL; Koleva, S; Lees, E; Mabbett, R; Muller, J; Munro, APS; Oliver, AL; Owens, DR; Pearce, JP; Rajan, M; Ratcliffe, H; Rowbotham, I; Salter, S; Sanders, H; Sapuan, SS; Sharpe, H; Sheehan, E; Sutton, N; Thaygaraja, G; Thomson-Hill, S; Ulaszewska, M; Woods, D; Bristol Clinical Research Nurse Team; Li, Grace ; Cappuccini, Federica ; Marchevsky, Natalie G ; Aley, Parvinder K; Aley, Robert; Anslow, Rachel; Bibi, Sagida; Cathie, Katrina; Clutterbuck, Elizabeth; Faust, Saul N; Feng, Shuo; Heath, Paul T; Kerridge, Simon; Lelliott, Alice; Mujadidi, Yama; Ng, Khuen Foong; Rhead, Sarah; Roberts, Hannah; Robinson, Hannah; Roderick, Marion R; Singh, Nisha; Smith, David; Snape, Matthew D; Song, Rinn; Tang, Karly; Yao, Andy; Liu, Xinxue ; Lambe, Teresa ; Pollard, Andrew J
Source
In The Lancet 11 June 2022 399(10342):2212-2225
Subject
Language
ISSN
0140-6736